Physical Address

304 North Cardinal St.
Dorchester Center, MA 02124

Vistagen targets transformative SAD drug approval with top-line PALISADE-3 data in Q4 2025 while advancing differentiated neuroscience pipeline



Vistagen targets transformative SAD drug approval with top-line PALISADE-3 data in Q4 2025 while advancing differentiated neuroscience pipeline



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *